Literature DB >> 12035938

Short children with familial short stature show enhancement of somatotroph secretion but normal IGF-I levels.

S Bellone1, G Corneli, J Bellone, C Baffoni, S Rovere, C de Sanctis, G Bona, E Ghigo, G Aimaretti.   

Abstract

The aim of the present study was to evaluate the GH status in children with familial, idiopathic short stature (FSS). To this goal we evaluated the GH response to GHRH (1 microg/kg iv) + arginine (ARG) (0.5 g/kg iv) test which is one of the most potent and reproducible provocative tests of somatotroph secretion, in 67 children with FSS [50 boys and 17 girls, age 10.8+/-0.4 yr, pubertal stages I-III, height between -3.6 and -1.6 standard deviation score (SDS), target height <10 degrees centile, normality of both spontaneous and stimulated GH secretion as well as of IGF-I levels]. The results in FSS were compared with those in groups of children of normal height (NHC) (42 NHC, 35 boys and 7 girls, age 12.0+/-0.5 yr, pubertal stages I-III, height between -1.3 and 1.4 SDS, height velocity standard deviation score (HVSDS)>25 degrees centile, GH peak >20 microg/l after GHRH+ARG test, mean GH concentration [mGHc]>3 microg/l) and children with organic GH deficiency (GHD) (38 GHD, 29 boys and 9 girls, age 11.2+/-3.7 yr, pubertal stages I-III, height between -5.7 and -1.3 SDS, GH peak <20 microg/l after GHRH +ARG test, mGHc <3 mg/l). Basal IGF-I levels and mGHc were also evaluated in each group over 8 nocturnal hours. IGF-I levels in FSS (209.2+/-15.6 microg/l) were similar to those in NHC (237.2+/-17.2 microg/l) and both were higher (p<0.0001) than those in GHD (72.0+/-4.0 microg/l). The GH response to GHRH +ARG test in FSS (peak: 66.4+/-5.6 microg/l) was very marked and higher (p<0.01) than that in NHC (53.3+/-4.5 microg/l) which, in turn, was higher (p<0.01) than in GHD (8.2+/-0.8 microg/l). Similarly, the mGHc in FSS was higher than in NHC (6.7+/-0.5 microg/l vs 5.1+/-0.7 microg/l, p<0.05) which, in turn, was higher than in GHD (1.5+/-0.2 microg/l, p<0.0001). In conclusion, our present study demonstrates that short children with FSS show enhancement of both basal and stimulated GH secretion but normal IGF-I levels. These findings suggest that increased somatotroph function would be devoted to maintain normal IGF-I levels thus reflecting a slight impairment of peripheral GH sensitivity in FSS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12035938     DOI: 10.1007/BF03344032

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   5.467


  36 in total

Review 1.  Congenital growth hormone insensitivity syndromes and their relevance to idiopathic short stature.

Authors:  P E Clayton; J S Freeth; M R Norman
Journal:  Clin Endocrinol (Oxf)       Date:  1999-03       Impact factor: 3.478

Review 2.  Should we treat children with idiopathic short stature?

Authors:  C J Kelnar; K Albertsson-Wikland; R L Hintz; M B Ranke; R G Rosenfeld
Journal:  Horm Res       Date:  1999

3.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

Review 4.  The diagnosis of growth hormone deficiency in children and adults.

Authors:  S M Shalet; A Toogood; A Rahim; B M Brennan
Journal:  Endocr Rev       Date:  1998-04       Impact factor: 19.871

5.  Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction.

Authors:  J Argente; N Caballo; V Barrios; J Pozo; M T Muñoz; J A Chowen; M Hernández
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

Review 6.  Insulin-like growth factors and their binding proteins: biological actions.

Authors:  J I Jones; D R Clemmons
Journal:  Endocr Rev       Date:  1995-02       Impact factor: 19.871

Review 7.  Clinical aspects of growth hormone deficiency in adults.

Authors:  H de Boer; G J Blok; E A Van der Veen
Journal:  Endocr Rev       Date:  1995-02       Impact factor: 19.871

Review 8.  Diagnosis of growth hormone deficiency.

Authors:  F Camanni
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

Review 9.  Partial growth hormone insensitivity.

Authors:  L B Johnston; M O Savage
Journal:  J Pediatr Endocrinol Metab       Date:  1999-04       Impact factor: 1.634

10.  Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group.

Authors:  R L Hintz; K M Attie; J Baptista; A Roche
Journal:  N Engl J Med       Date:  1999-02-18       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.